Cargando…
EHMTI-0021. The possible effect of telmisartan on the blood-brain barrier transport of verapamil
Autores principales: | Saaby, PL, Tfelt-Hansen, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182229/ http://dx.doi.org/10.1186/1129-2377-15-S1-F28 |
Ejemplares similares
-
The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1
por: Saaby, Lasse, et al.
Publicado: (2015) -
EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
por: Pavbro, P, et al.
Publicado: (2014) -
EHMTI-0016. Examples of problematic use of references in the headache literature. A problem for readers, authors, referees, and editors ?
por: Tfelt-Hansen, P
Publicado: (2014) -
EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
por: Tfelt-Hansen, P, et al.
Publicado: (2014) -
EHMTI-0368. Treatment of migraine attacks as suggested by Dr. John R. Graham in 1955. A historical analysis with current implications
por: Tfelt-Hansen, P, et al.
Publicado: (2014)